Home LiteratureArticle Details
PMID: 12606712 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Crystal structure of the receptor-binding domain of human B7-2: insights into organization and signaling.

Zhang X, Schwartz JC, Almo SC, Nathenson SG

Abstract

B7-1 and B7-2 are homologous costimulatory ligands expressed on the surfaces of antigen-presenting cells. Their interactions with CD28/CTLA-4 receptors expressed on T cell surfaces are crucial for the proper regulation of T cell activity. B7-1 and B7-2 display distinct roles in immune regulation, although they are usually considered to have redundant functions. Here, we report the crystal structure of the receptor-binding (Ig V-type) domain of human B7-2 at 2.7-A resolution. Structures of unliganded and liganded B7-1 and B7-2 suggest a physical-chemical basis for the observed functional similarities and differences between these two costimulatory ligands. Of particular note, whereas the majority of the residues mediating B7-1 dimerization are hydrophobic, the B7-2 dimer observed in the B7-2/CTLA-4 complex displays a very hydrophilic dimer interface. These differences provide a mechanism for preventing the formation of B7-1/B7-2 heterodimers. The divergence at the putative dimer interface is also consistent with the lower tendency of B7-2 to dimerize, as shown by the monomeric state of unliganded B7-2 both in solution and crystalline form, and may result in detailed differences in signaling mechanisms associated with B7-1 and B7-2.

MeSH Terms
Abatacept Amino Acid Sequence Antigens, CD/chemistry,metabolism Antigens, Differentiation/biosynthesis B7-1 Antigen/chemistry B7-2 Antigen CD28 Antigens/biosynthesis CTLA-4 Antigen Crystallography, X-Ray Dimerization Humans Immunoconjugates Ligands Membrane Glycoproteins/chemistry,metabolism Models, Molecular Molecular Sequence Data Protein Binding Protein Folding Protein Structure, Secondary Protein Structure, Tertiary Sequence Homology, Amino Acid Signal Transduction Ultracentrifugation
Chemicals
Antigens, CD Antigens, Differentiation B7-1 Antigen B7-2 Antigen CD28 Antigens CD86 protein, human CTLA-4 Antigen CTLA4 protein, human Immunoconjugates Ligands Membrane Glycoproteins Abatacept
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Zhang Xuewu
Department of Cell Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
Schwartz Jean-Claude D
Almo Steven C
Nathenson Stanley G
References (41)
41 references, click to expand
  1. Automated MAD and MIR structure solution.
    Acta Crystallogr D Biol Crystallogr. 1999 Apr;55(Pt 4):849-61 PMID: 10089316
  2. Structure and dimerization of a soluble form of B7-1.
    Immunity. 2000 Jan;12(1):51-60 PMID: 10661405
  3. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.
    Annu Rev Immunol. 2001;19:565-94 PMID: 11244047
  4. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.
    Nature. 2001 Mar 29;410(6828):604-8 PMID: 11279501
  5. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses.
    Nature. 2001 Mar 29;410(6828):608-11 PMID: 11279502
  6. The immunological synapse and CD28-CD80 interactions.
    Nat Immunol. 2001 Dec;2(12):1159-66 PMID: 11713465
  7. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma.
    J Biol Chem. 2002 Mar 8;277(10):7766-75 PMID: 11726649
  8. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength.
    Immunity. 2002 Jan;16(1):23-35 PMID: 11825563
  9. Expression, refolding, purification, molecular characterization, crystallization, and preliminary X-ray analysis of the receptor binding domain of human B7-2.
    Protein Expr Purif. 2002 Jun;25(1):105-13 PMID: 12071705
  10. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.
    Proteins. 1991;11(4):281-96 PMID: 1758883
  11. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.
    J Exp Med. 1991 Mar 1;173(3):721-30 PMID: 1847722
  12. Protein multiple sequence alignment and flexible pattern matching.
    Methods Enzymol. 1990;183:403-28 PMID: 2314284
  13. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.
    Proc Natl Acad Sci U S A. 1989 Feb;86(4):1333-7 PMID: 2465550
  14. Processing of X-ray diffraction data collected in oscillation mode.
    Methods Enzymol. 1997;276:307-26 PMID: 27754618
  15. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.
    J Immunol. 1989 Oct 15;143(8):2714-22 PMID: 2794510
  16. A new member of the immunoglobulin superfamily--CTLA-4.
    Nature. 1987 Jul 16-22;328(6127):267-70 PMID: 3496540
  17. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.
    Science. 1995 Nov 10;270(5238):985-8 PMID: 7481803
  18. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.
    Cell. 1995 Mar 10;80(5):707-18 PMID: 7534215
  19. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
    Immunity. 1994 Dec;1(9):793-801 PMID: 7534620
  20. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4.
    Immunity. 1995 May;2(5):523-32 PMID: 7538442
  21. Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28.
    J Biol Chem. 1995 Sep 8;270(36):21181-7 PMID: 7545666
  22. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.
    Immunity. 1995 Nov;3(5):541-7 PMID: 7584144
  23. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.
    Science. 1993 Nov 5;262(5135):909-11 PMID: 7694363
  24. CTLA-4 can function as a negative regulator of T cell activation.
    Immunity. 1994 Aug;1(5):405-13 PMID: 7882171
  25. Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 A resolution.
    Structure. 1994 Aug 15;2(8):755-66 PMID: 7994575
  26. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.
    Nature. 1993 Jul 1;364(6432):33-9 PMID: 8316295
  27. SETOR: hardware-lighted three-dimensional solid model representations of macromolecules.
    J Mol Graph. 1993 Jun;11(2):134-8, 127-8 PMID: 8347566
  28. Principles of protein-protein interactions.
    Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):13-20 PMID: 8552589
  29. Dali: a network tool for protein structure comparison.
    Trends Biochem Sci. 1995 Nov;20(11):478-80 PMID: 8578593
  30. Interactions of CD80 and CD86 with CD28 and CTLA4.
    J Immunol. 1996 Apr 15;156(8):2700-9 PMID: 8609386
  31. Analysis of the site of interaction of CD28 with its counter-receptors CD80 and CD86 and correlation with function.
    J Immunol. 1996 Jul 1;157(1):29-38 PMID: 8683128
  32. CD28/B7 system of T cell costimulation.
    Annu Rev Immunol. 1996;14:233-58 PMID: 8717514
  33. Transmembrane signaling through CD80 (B7-1) induces growth arrest and cell spreading of human B lymphocytes accompanied by protein tyrosine phosphorylation.
    Immunol Lett. 1996 Apr;50(1-2):95-8 PMID: 8793565
  34. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions.
    J Biol Chem. 1996 Oct 25;271(43):26762-71 PMID: 8900156
  35. CD80 costimulation is essential for the induction of airway eosinophilia.
    J Exp Med. 1997 Jan 6;185(1):177-82 PMID: 8996254
  36. CD86 (B7-2) on human B cells. A functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells.
    J Biol Chem. 1997 Jun 20;272(25):15613-9 PMID: 9188449
  37. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion.
    Int Immunol. 1997 Jun;9(6):805-13 PMID: 9199963
  38. Anatomy of hot spots in protein interfaces.
    J Mol Biol. 1998 Jul 3;280(1):1-9 PMID: 9653027
  39. The assembly and stability of MHC class II-(alpha beta)2 superdimers.
    J Immunol. 1998 Sep 1;161(5):2307-16 PMID: 9725225
  40. Crystallography & NMR system: A new software suite for macromolecular structure determination.
    Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21 PMID: 9757107
  41. Miscellaneous algorithms for density modification.
    Acta Crystallogr D Biol Crystallogr. 1998 Jul 1;54(Pt 4):487-93 PMID: 9761844
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2003-03-04
Epub
2003-00-26
Pages
2586-91
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC151384
Subset
IM
Grants
NCI NIH HHS · T32 CA009173 · United States
NIAID NIH HHS · R56 AI007289 · United States
NCI NIH HHS · T32CA09173 · United States
NCI NIH HHS · P30CA13330 · United States
NIAID NIH HHS · AI07289 · United States
NIAID NIH HHS · R01 AI007289 · United States
NCI NIH HHS · P30 CA013330 · United States
Databases
PDB
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com